GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have changed how many people manage diabetes and weight, and they can also lower some heart and kidney risks. Because so many people now take them, researchers keep looking for less obvious side effects. A new study led by Rutgers researchers points to a place many patients never think about: the optic nerve.
What the researchers studied
The team, publishing in the Annals of Internal Medicine, analyzed a large database of U.S. adults ages 18 to 65 with type 2 diabetes who had recently started a medication for their condition. They looked for ischemic optic neuropathy, a problem in which blood flow to the optic nerve drops. The optic nerve carries visual information from the eye to the brain, so when its blood supply falters, vision can be damaged suddenly.
What they found
Starting a GLP-1 drug was linked to a modest increase in risk. In real numbers, the researchers estimated roughly three to four additional cases per 10,000 patients treated over 18 months. Most people who developed the condition were men, or adults in the older part of the study group (ages 50 to 65).
More than 80% of ischemic optic neuropathy cases involve the non-arteritic anterior form, in which the front portion of the optic nerve does not get enough blood. The authors were clear that their study shows an association, not proof that the drugs cause the damage. Differences in patients’ underlying health could explain part of the signal, and more research is needed.
Why this is an eye-body story
The optic nerve shares its blood supply with the rest of the body, and diabetes, blood pressure, and other vascular conditions all affect it. I see this study less as a reason to panic and more as a reminder that the medicines we take for the whole body can show up in the eye, and that the eye is often where early warning signs appear.
Symptoms that need prompt attention
According to the study team, this condition usually affects part of the vision in one eye rather than causing total blindness. Watch for:
- Sudden blurriness or dimming in one eye
- A missing area in your field of view
- A change that does not clear with blinking or rest
About one-third of affected patients see some recovery, usually during the first six months, but some impairment typically remains. That is why early evaluation matters.
My advice if you take a GLP-1 medication
- Do not stop a prescribed medicine on your own; talk with the doctor who prescribed it.
- Tell your eye doctor about every medication you take, including weight-loss drugs.
- If you are a man or between 50 and 65, be especially alert to sudden vision changes.
- Keep up with dilated eye exams, especially if you have diabetes.
Sudden vision loss should be examined right away. When an exam points to an optic nerve problem, we refer patients to a neuro-ophthalmologist or the appropriate specialist and help coordinate care.
For more on keeping the optic nerve healthy, the articles on glaucoma screening at Thousand Oaks Lasik are a good next read.
Source: Ozempic and Wegovy linked to rare risk of sudden vision loss (ScienceDaily, materials from Rutgers University, 10/14/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.